Screener
LeMaitre Vascular LMAT Acquisitions
Acquisitions at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|
| Investing activities | ||
| Purchases of short-term marketable securities | (231,434) | (17,849) |
| Purchases of property and equipment | (5,096) | (2,725) |
| Payments related to acquisitions, net of cash acquired | (158) | (95) |
| Proceeds from short-term marketable securities | 212,489 | — |
| Net cash used in investing activities | (24,199) | (20,669) |
| Financing activities | ||
| Proceeds from stock option exercises | 3,728 | 3,072 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's acquisitions?
- LeMaitre Vascular (LMAT) reported acquisitions of $113K in Q2 2026.
- How has LeMaitre Vascular's acquisitions changed year-over-year?
- LeMaitre Vascular's acquisitions increased by 121.6% year-over-year, from $51K to $113K.
- What does acquisitions mean?
- Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.
Ask your AI about LeMaitre Vascular's acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude